Viewing Study NCT03484520


Ignite Creation Date: 2025-12-25 @ 4:28 AM
Ignite Modification Date: 2026-03-06 @ 9:38 AM
Study NCT ID: NCT03484520
Status: TERMINATED
Last Update Posted: 2022-12-30
First Post: 2018-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer - Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cancer, Acute Myeloid Leukemia (AML), venetoclax, dinaciclib, Relapsed/refractory AML, Pharmacokinetics, … View